NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 365 filers reported holding NEKTAR THERAPEUTICS in Q1 2018. The put-call ratio across all filers is 0.43 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $32,393 | -36.5% | 14,333 | -10.0% | 0.00% | – |
Q3 2022 | $51,000 | -15.0% | 15,921 | 0.0% | 0.00% | – |
Q2 2022 | $60,000 | -32.6% | 15,921 | -3.4% | 0.00% | – |
Q1 2022 | $89,000 | -60.1% | 16,488 | 0.0% | 0.00% | -100.0% |
Q4 2021 | $223,000 | -12.9% | 16,488 | +17.5% | 0.00% | -50.0% |
Q3 2019 | $256,000 | -48.8% | 14,032 | -0.2% | 0.00% | -33.3% |
Q2 2019 | $500,000 | +8.9% | 14,059 | +3.0% | 0.00% | 0.0% |
Q1 2019 | $459,000 | +0.9% | 13,656 | -1.4% | 0.00% | 0.0% |
Q4 2018 | $455,000 | -46.0% | 13,850 | +0.3% | 0.00% | -40.0% |
Q3 2018 | $842,000 | +24.0% | 13,812 | -0.7% | 0.01% | +25.0% |
Q2 2018 | $679,000 | -52.1% | 13,915 | +4.4% | 0.00% | -55.6% |
Q1 2018 | $1,417,000 | +338.7% | 13,334 | +146.2% | 0.01% | +350.0% |
Q4 2017 | $323,000 | +19.6% | 5,415 | -51.8% | 0.00% | 0.0% |
Q3 2017 | $270,000 | +33.0% | 11,240 | +8.4% | 0.00% | +100.0% |
Q2 2017 | $203,000 | -16.5% | 10,366 | 0.0% | 0.00% | -50.0% |
Q1 2017 | $243,000 | +91.3% | 10,366 | 0.0% | 0.00% | +100.0% |
Q4 2016 | $127,000 | – | 10,366 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Strong Tower Advisory Services | 404,972 | $6,913,000 | 4.02% |
GREAT POINT PARTNERS LLC | 504,691 | $9,064,000 | 2.11% |
Camber Capital Management LP | 3,750,000 | $67,350,000 | 2.07% |
ACT CAPITAL MANAGEMENT, LLC | 161,500 | $2,901,000 | 1.50% |
Rhenman & Partners Asset Management AB | 950,000 | $17,062,000 | 1.20% |
MAVERICK CAPITAL LTD | 5,838,426 | $104,858,000 | 1.06% |
Birchview Capital, LP | 72,000 | $1,293,000 | 0.88% |
Bellevue Group AG | 4,594,656 | $82,519,000 | 0.84% |
CM Management, LLC | 50,000 | $898,000 | 0.67% |
Duquesne Family Office | 1,000,000 | $17,960,000 | 0.58% |